Trail Antibody  0.1mg

from Prosci
Code Prosci-1113-01 Price
AU$350.00+GST
Applications E, WB, IHC Clonality pAb
Reactivity H Availability Order today and receive it by Fri, 24 Feb 2012
Order: Tel: 1300 543 373, Email: info@liferesearch.com, Fax: 03 8648 5841 OR
Product Type Antibodies - Primary Antibody

Trail Antibody

Double click on above image to view full picture

Zoom Out
Zoom In
Description Apoptosis, or programmed cell death, occurs during normal cellular differentiation and development of multicellular organisms. Apoptosis is induced by certain cytokines including TNF and Fas ligand in the TNF family through their death domain containing receptors, TNFR1 and Fas. A novel member in the TNF family was recently identified and designated TRAIL (for TNF-related apoptosis-inducing ligand) and Apo-2L (for Apo-2 ligand)1,TRAIL is a type II membrane protein and expressed in a variety of human tissues. Two novel death domain containing receptors DR4 and DR5 have been identified as the receptor for TRAIL3-6. Like TNF and Fas ligand, TRAIL induces apoptosis and NF-kappaB activation in many tissues and cells.
Protein GI No.: 4507593
Protein Accession No.: NP_003801
Blocking peptide: Cat. No. 1113P - Trail Peptide
Positive Controls: Cat. No. 1201 - HeLa Cell Lysate
Cat. No. 1303 - Human Brain Tissue Lysate
Note: other product sizes available
Other Name Trail (CT), Apo-2L
Application Notes TRAIL antibody can be used for detection of TRAIL by Western blot at 1 μg/ml dilution.
Immunogen
Antibody was raised against a peptide corresponding to amino acids near the carboxy terminus of human TRAIL.
Raised In Rabbit
Purity Ion exchange chromatography purified
Data Sheet Click to download Data Sheet
Storage Buffer Antibody is supplied in PBS containing 0.02% sodium azide.
Storage Instructions Trail antibody can be stored at 4°C, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
References Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA, et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995;3:673-682
Pitti RM; Marsters SA; Ruppert S; Donahue CJ; Moore A; Ashkenazi A. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J. Biol. Chem. 1996;271:12687-90
Pan G; O'Rourke K; Chinnaiyan AM; O'Rourke K; Gentz R; Ebner R; Ni J; Dixit VM. The receptor for the cytotoxic ligand TRAIL. Science; 1997;276:111-113
Schneider P, Thome M, Burns K, Bodmer JL, Hofmann K, Kataoka T, Holler N, Tschopp J. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-κB. Immunity 1997;7:831-836